Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Embryonic stem cells: a promising tool for cell replacement therapy.

Michael Xavier Doss1, Christoph I Koehler, C Gissel

  • 1University of Cologne, Center of Physiology and Pathophysiology, Institute of Neurophysiology, Robert-Koch Strasse 39, 50931 Cologne, Germany.

Journal of Cellular and Molecular Medicine
|December 17, 2004
PubMed
Summary

Embryonic stem (ES) cells offer a promising renewable source for cell replacement therapy (CRT). Research shows their potential to repair damaged tissues in degenerative diseases, though practical challenges remain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structured, evidence-based debate in science: Introducing a new forum.

EXCLI journal·2026
Same author

The problem of weak AI-generated graphical abstracts.

EXCLI journal·2026
Same author

Scalable differentiation of human cardiac organoids from iPSCs generates cardiac tissues for cardiac cell therapy.

Theranostics·2026
Same author

Acute Depletion of Cited2 in Embryonic Stem Cells Disrupts Gene Networks Controlling Self-Renewal, Homeostasis, and Early Cell Fate Commitment.

Cells·2026
Same author

Loss of MLKL impairs abdominal aortic aneurysm development by attenuating smooth muscle cell necroptosis.

Cell death & disease·2026
Same author

Sex-specific cortical, hippocampal and thalamic whole genome transcriptome data from controls and a G72 schizophrenia mouse model.

BMC research notes·2024

Area of Science:

  • Developmental Biology
  • Stem Cell Research
  • Regenerative Medicine

Background:

  • Embryonic stem (ES) cells, derived from the inner cell mass (ICM) of early embryos, possess indefinite self-renewal capacity in vitro.
  • These pluripotent cells can differentiate into all somatic cell types, making them valuable for developmental biology studies.
  • ES cells hold significant promise for cell replacement therapy (CRT) in treating degenerative diseases.

Purpose of the Study:

  • To review the progress of ES cell research in CRT.
  • To discuss challenges hindering the practical application of ES cells in CRT.
  • To evaluate the experimental success of ES cell-based therapies.

Main Methods:

  • Literature review of current ES cell research.

Related Experiment Videos

  • Analysis of experimental data from ES cell applications.
  • Discussion of challenges and future directions in ES cell therapy.

    • Main Results:

    • ES cells offer a potentially unlimited source for cell replacement.
    • Promising results from mouse models indicate therapeutic potential for diseases like diabetes, myocardial infarction, and Parkinson's.
    • Significant hurdles exist in the practical implementation of ES cell-based CRT.

    Conclusions:

    • ES cells represent a revolutionary tool for understanding differentiation and developing novel therapies.
    • Further research is needed to overcome practical challenges for successful clinical translation of ES cell-based CRT.
    • ES cell technology offers hope for treating a wide range of degenerative conditions.